Impax Asset Management’s Core Laboratories CLB Stock Holding History

Impax Asset Management’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-13,121	Closed	-$1.63M	–	188
2016 Q2	$1.63M	Sell	13,121 -8,160	-38%	-$985K	0.09%	132
2016 Q1	$2.39M	Sell	21,281 -9,077	-30%	-$943K	0.13%	139
2015 Q4	$3.3M	Sell	30,358 -14,916	-33%	-$1.71M	0.18%	114
2015 Q3	$4.52M	Sell	45,274 -20	-0%	-$2.17K	0.27%	99
2015 Q2	$5.17M	Sell	45,294 -7,022	-13%	-$851K	0.28%	104
2015 Q1	$5.47M	Buy	52,316 +14	+0%	+$1.49K	0.3%	96
2014 Q4	$6.29M	Buy	+52,302	New	+$6.87M	0.37%	63

Other funds holding CLB

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Wedgewood Partners St Louis, Missouri $484M AUM 16.04% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

SGA

Sustainable Growth Advisers Stamford, Connecticut $10.2B AUM 1.48% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Emerald Acquisition Seattle, Washington $51.8B AUM

Impax Asset Management's CLB Position: Q3 2016 in Review

Impax Asset Management sold out of Core Laboratories (CLB) in Q3 2016, closing a stake of 13,121 shares — an estimated $1.63M sold.

Impax Asset Management first reported a position in CLB in Q4 2014 and held it in 7 quarters. The position peaked at $6.29M in Q4 2014. 374 funds tracked by Wall St. Rank hold CLB as of Q3 2016.

Impax Asset Management reported no remaining Core Laboratories position as of Q3 2016 after selling out during the quarter.
Impax Asset Management sold 13,121 Core Laboratories shares in Q3 2016, an estimated $1.63M.
Impax Asset Management first reported a position in Core Laboratories in Q4 2014 and held it in 7 quarters.
Impax Asset Management's Core Laboratories position peaked at $6.29M in Q4 2014.
374 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2016.

Based on Impax Asset Management's 13F filing for Q3 2016, filed 9 Nov 2016.